Equillium Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
EQ Nasdaq 2834 https://www.equilliumbio.com/home/default.aspx

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Equillium Inc

Equillium to Present at the Cantor Fitzgerald Global Healthcare & LD Micro Main Event Conferences - Sep 20th, 2023 12:00 pm
Equillium to Attend Wells Fargo Healthcare Conference & Present at H.C. Wainwright 25th Annual Global Investor Conference - Aug 30th, 2023 12:00 pm
Analysts Have Updated Equillium, Inc. (NASDAQ:EQ) Forecasts - Aug 14th, 2023 10:01 am
Equillium, Inc. (NASDAQ:EQ) Just Reported, And Analysts Assigned A US$6.06 Price Target - Aug 12th, 2023 12:05 pm
Equillium, Inc. (EQ) Reports Q2 Loss, Tops Revenue Estimates - Aug 9th, 2023 9:30 pm
Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates - Aug 9th, 2023 8:01 pm
Equillium Announces $7.5 Million Share Repurchase Program - Aug 2nd, 2023 8:00 pm
Equillium to Present at the Jefferies Global Healthcare & LD Micro Invitational Conferences - Jun 1st, 2023 12:00 pm
Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists - May 15th, 2023 12:00 pm
Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue Estimates - May 11th, 2023 9:25 pm
Equillium Reports First Quarter 2023 Financial Results and Provides Clinical Updates - May 11th, 2023 8:01 pm
News Flash: Analysts Just Made A Meaningful Upgrade To Their Equillium, Inc. (NASDAQ:EQ) Forecasts - May 3rd, 2023 10:14 am
Equillium Announces Poster Presentation at the Annual Meeting of the European Society for Blood and Marrow Transplantation - Apr 24th, 2023 12:00 pm
Equillium Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate & Clinical Development Updates - Mar 23rd, 2023 8:01 pm
Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference - Mar 22nd, 2023 12:00 pm
Equillium Announces Oral Presentation at the Tandem Meetings of ASTCT and CIBMTR - Feb 17th, 2023 1:00 pm
Equillium to Present at the SVB Securities Annual Global Healthcare Conference - Feb 7th, 2023 1:00 pm
Equillium Announces Abstract Accepted for Oral Presentation at the Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR - Jan 13th, 2023 1:00 pm
Equillium and Metacrine Mutually Agree to Terminate Definitive Merger Agreement - Dec 23rd, 2022 9:01 pm
Equillium’s Partner Biocon Initiates Phase 2 Study of Itolizumab in Ulcerative Colitis - Dec 16th, 2022 1:00 pm